High-Dose Aumolertinib Combined Intrathecal Chemotherapy for LM from EGFR-Mutated NSCLC with Meningeal Symptoms as the First Symptom

被引：0
|
作者：
Wang, W. [1 ,2 ]
Fan, S. B. [1 ]
Huang, X. P. [1 ]
Zhong, M. X. [1 ]
Guo, J. [1 ]
机构：
[1] Chongqing Univ Three Gorges Hosp, Ctr Canc, Chongqing, Peoples R China
[2] Chongqing Municipal Clin Res Ctr Geriatr Dis, Chongqing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
aumolertinib; intrathecal chemotherapy; leptomeningeal metastasis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP12.01-24
引用
收藏
页码：S650 / S650
页数：1
相关论文
共 50 条
  • [31] High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, Haiyang
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    Yang, Sen
    He, Zhen
    Mo, Yuqing
    Zhang, Cuicui
    Wang, Qiming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [32] Real-world clinical outcomes in Chinese patients with EGFR-mutated NSCLC progressed from first-line EGFR-TKI: A prospective multicenter study
    Tian, Panwen
    Wu, Lin
    Zhou, Chengzhi
    Tan, Jie
    Wang, Ke
    Luo, Feng
    Liu, Yongmei
    Guo, Yubiao
    Li, Yinyin
    Liu, Zhe
    Gong, Youling
    Wang, Yongsheng
    Li, Weimin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment
    Reckamp, K.
    Nieva, J.
    Taylor, A.
    Thakrar, B.
    Wong, J.
    Potter, D.
    Bakker, N.
    Rubinstein, W.
    Sun, P.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S402 - S402
  • [34] Effectiveness of high-dose third-generation EGFR-tyrosine kinase inhibitors in treating EGFR-mutated non-small cell lung cancer patients with leptomeningeal metastasis
    Wu, Haicheng
    Zhang, Qian
    Zhai, Wanchen
    Chen, Yunfei
    Yang, Yehao
    Xie, Mingning
    Huang, Zhiyu
    Xu, Yanjun
    Li, Hui
    Gong, Lei
    Yu, Sizhe
    Fan, Yun
    Chen, Kaiyan
    LUNG CANCER, 2024, 188
  • [35] Treatment response to intrathecal chemotherapy with pemetrexed via an Ommaya reservoir in EGFR-mutated leptomeningeal metastases from non-small cell lung cancer: a case report
    Li, Huiying
    Lin, Yongjuan
    Yu, Tingting
    Xie, Yu
    Feng, Jie
    Huang, Mingmin
    Guo, Aibin
    Liu, Xiangyu
    Yin, Zhenyu
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (04) : 2341 - 2346
  • [36] Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR plus NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
    Saalfeld, F. C.
    Moeller, J.
    Michels, S.
    Grohe, C.
    Wiesweg, M.
    Schubart, C.
    Alt, J.
    Griesinger, F.
    Kauffmann-Guerrero, D.
    Kulhavy, J.
    Overbeck, T. R.
    Pelusi, N.
    Rohde, G.
    Wesseler, C.
    Vathiotis, I.
    Veluswamy, R.
    Illini, O. M.
    Rothschild, S. I.
    Christopoulos, P.
    Wermke, M.
    ANNALS OF ONCOLOGY, 2023, 34
  • [37] High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib
    Kuiper, J. L.
    Heideman, D. A. M.
    Thunnissen, E.
    van Wijk, A. W.
    Postmus, P. E.
    Smit, E. F.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (07) : 1399 - 1401
  • [38] Efficacy of ramucirumab combined with erlotinib or osimertinib in untreated EGFR-mutated NSCLC patients with asymptomatic brain metastases: insights from molecular biomarkers in the RELAY-brain trial
    Kaneda, Hiroyasu
    Daga, Haruko
    Okada, Asuka
    Nakatani, Yuki
    Tani, Yoko
    Oka, Takako
    Sawa, Kenji
    Sakai, Kazuko
    Nishio, Kazuto
    Kawaguchi, Tomoya
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 147 - 156
  • [39] Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC: Results From the FURLONG Study
    Shi, Yuankai
    Chen, Gongyan
    Wang, Xiang
    Liu, Yunpeng
    Wu, Lin
    Hao, Yanrong
    Liu, Chunling
    Zhu, Shuyang
    Zhang, Xiaodong
    Li, Yuping
    Liu, Jiwei
    Cao, Lejie
    Cheng, Ying
    Zhao, Hui
    Zhang, Shucai
    Zang, Aimin
    Cui, Jiuwei
    Feng, Jian
    Yang, Nong
    Liu, Fei
    Jiang, Yong
    Gu, Chuan
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (11) : 1297 - 1305
  • [40] First report of cohort 3 and mature survival data from the U31402-A-U102 study of HER3-DXd in EGFR-mutated NSCLC
    Hayashi, Hidetoshi
    Yu, Helena A.
    Baik, Christina
    Kim, Dong-Wan
    Johnson, Melissa L.
    Nishio, Makoto
    Yang, James Chih-Hsin
    Su, Wu-Chou
    Gold, Kathryn A.
    Koczywas, Marianna
    Smit, Egbert F.
    Steuer, Conor
    Felip, Enriqueta
    Murakami, Haruyasu
    Kim, Sang-We
    Kim, Ben
    Su, Xin
    Tanaka, Yoshimi
    Fan, Pang-Dian
    Cantero, Frederique
    ANNALS OF ONCOLOGY, 2023, 34 : S1379 - S1379
12345